Exchange: OTC·Updated 11:16 AM EDT
IOBTQ logo

IOBTQ IO Biotech Inc

$0.0002
$0.0001
(33.33%)
Today
Mkt Cap$21,585.00
Vol2,149.00

About IOBTQ

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
62

Bullish Sentiment

How do you feel about IOBTQ?

Advertisement|Remove ads.